NSE BSE
zenotech laboratories ltd. stock

ZENOTECH LABORATORIES LTD. Share Price

- - (%)
- NSE: ZENOTECH

ZENOTECH LABORATORIES LTD. Share Price Update

As of the latest trading session, ZENOTECH LABORATORIES LTD. share price is currently at 65.78, which is down by -1.02 from its previous closing. Today, the stock has fluctuated between 64.50 and 69.00. Over the past year, ZENOTECH LABORATORIES LTD. has achieved a return of 23.65 %. In the last month alone, the return has been 15.37 %. Read More...

ZENOTECH LABORATORIES LTD. Performance

Day Range

Low64.50 High69.00
66.80

52 Week Range

Low 52.00 High 81.00
66.80

ZENOTECH LABORATORIES LTD. Share Price

532039

ZENOTECH

img img img img
No Data Available

Open Price

67.99

Prev. Close

66.80

Volume (Shares)

33766.00

Total traded value

23.01

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

ZENOTECH LABORATORIES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 407.70
PE Ratio (TTM) 50.81
Book Value / Share 14.83
Beta 0.85
ROE 4.28%
EPS (TTM) 1.36
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.66

ZENOTECH LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 8.09
Operating Expense 8.06
Net Profit 0.66
Net Profit Margin (%) 8.15
Earnings Per Share (EPS) 0.11
EBITDA 3.10
Effective Tax Rate (%) 51.82
Particulars DEC 2023 (Values in Cr)
Revenue 9.92
Operating Expense 7.42
Net Profit 3.36
Net Profit Margin (%) 33.87
Earnings Per Share (EPS) 0.55
EBITDA 5.54
Effective Tax Rate (%) 11.57
Particulars SEP 2023 (Values in Cr)
Revenue 10.51
Operating Expense 7.82
Net Profit 2.83
Net Profit Margin (%) 26.92
Earnings Per Share (EPS) 0.46
EBITDA 5.71
Effective Tax Rate (%) 27.17
Particulars JUN 2023 (Values in Cr)
Revenue 8.24
Operating Expense 7.39
Net Profit 1.44
Net Profit Margin (%) 17.47
Earnings Per Share (EPS) 0.24
EBITDA 3.87
Effective Tax Rate (%) 29.95
Particulars MAR 2023 (Values in Cr)
Revenue 9.96
Operating Expense 7.72
Net Profit 3.67
Net Profit Margin (%) 36.84
Earnings Per Share (EPS) 0.60
EBITDA 5.26
Effective Tax Rate (%) -5.17
Particulars MAR 2024 (Values in Cr)
Revenue 36.76
Operating Expense 30.70
Net Profit 8.30
Net Profit Margin (%) 22.57
Earnings Per Share (EPS) 1.36
EBITDA 18.23
Effective Tax Rate (%) 25.49
Particulars MAR 2023 (Values in Cr)
Revenue 38.35
Operating Expense 29.00
Net Profit 11.59
Net Profit Margin (%) 30.22
Earnings Per Share (EPS) 1.90
EBITDA 21.78
Effective Tax Rate (%) 20.13
Particulars MAR 2022 (Values in Cr)
Revenue 32.49
Operating Expense 27.29
Net Profit 22.18
Net Profit Margin (%) 68.26
Earnings Per Share (EPS) 3.63
EBITDA 18.09
Effective Tax Rate (%) -123.93
Particulars MAR 2021 (Values in Cr)
Revenue 19.37
Operating Expense 24.07
Net Profit -1.22
Net Profit Margin (%) -6.29
Earnings Per Share (EPS) -0.20
EBITDA 6.79
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 25.94
Operating Expense 22.78
Net Profit 10.78
Net Profit Margin (%) 41.55
Earnings Per Share (EPS) 1.77
EBITDA 16.52
Effective Tax Rate (%) 0.00
Particulars MAR 2010 (Values in Cr)
Book Value / Share 28.01
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin -105.78
Particulars MAR 2009 (Values in Cr)
Book Value / Share 31.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.15
EBITDA Margin -198.17
Particulars MAR 2008 (Values in Cr)
Book Value / Share 36.79
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.30
EBITDA Margin -89.96
Particulars MAR 2007 (Values in Cr)
Book Value / Share 18.80
ROE % 3.92
ROCE % 1.59
Total Debt to Total Equity 0.77
EBITDA Margin 22.66
Particulars MAR 2006 (Values in Cr)
Book Value / Share 13.61
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.97
EBITDA Margin -18.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.48
ROE % 4.28
ROCE % 5.31
Total Debt to Total Equity 0.04
EBITDA Margin 51.37
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.57
ROE % 13.91
ROCE % 6.37
Total Debt to Total Equity 0.22
EBITDA Margin 49.47
Particulars MAR 2021 (Values in Cr)
Book Value / Share 7.93
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.43
EBITDA Margin 30.24
Particulars MAR 2020 (Values in Cr)
Book Value / Share 8.13
ROE % 2.85
ROCE % 3.01
Total Debt to Total Equity 0.47
EBITDA Margin 39.01
Particulars MAR 2019 (Values in Cr)
Book Value / Share 6.37
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.25
EBITDA Margin 9.21
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.14
Total Assets 100.87
Total Liabilities 100.87
Total Equity 82.27
Share Outstanding 61030568
Price to Book Ratio 3.49
Return on Assets (%) 11.48
Return on Capital (%) 14.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.41
Total Assets 94.08
Total Liabilities 94.08
Total Equity 70.64
Share Outstanding 61030568
Price to Book Ratio 4.35
Return on Assets (%) 23.57
Return on Capital (%) 28.94
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.45
Total Assets 85.84
Total Liabilities 85.84
Total Equity 48.40
Share Outstanding 61030568
Price to Book Ratio 4.41
Return on Assets (%) -1.41
Return on Capital (%) -1.76
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.12
Total Assets 85.55
Total Liabilities 85.55
Total Equity 49.62
Share Outstanding 61030568
Price to Book Ratio 1.81
Return on Assets (%) 12.59
Return on Capital (%) 15.78
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 13.25
Total Assets 84.58
Total Liabilities 84.58
Total Equity 38.89
Share Outstanding 61030568
Price to Book Ratio 3.34
Return on Assets (%) -3.69
Return on Capital (%) -5.29
Particulars MAR 2023 (Values in Cr)
Net Income 14.50
Cash from Operations 21.85
Cash from Investing -5.82
Cash from Financing -6.11
Net change in Cash 8.72
Free Cash Flow 28.08
Particulars MAR 2022 (Values in Cr)
Net Income 9.90
Cash from Operations 18.67
Cash from Investing -1.83
Cash from Financing -15.87
Net change in Cash -0.04
Free Cash Flow 20.60
Particulars MAR 2021 (Values in Cr)
Net Income -1.21
Cash from Operations 5.85
Cash from Investing -4.81
Cash from Financing 0.45
Net change in Cash 1.37
Free Cash Flow 10.76
Particulars MAR 2020 (Values in Cr)
Net Income 10.77
Cash from Operations 11.66
Cash from Investing -20.79
Cash from Financing -2.70
Net change in Cash -12.11
Free Cash Flow 33.40
Particulars MAR 2019 (Values in Cr)
Net Income -3.12
Cash from Operations -13.58
Cash from Investing -16.18
Cash from Financing 15.02
Net change in Cash -15.20
Free Cash Flow 4.44
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 114.00 12.46 1.23 1194.01 77.65 / 148.95
CIPLA LTD 1511.35 28.66 4.56 122044.23 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 213.15 0.00 2.16 627.32 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2611.55 67.38 24.88 44241.23 1376.50 / 2759.00
SANOFI INDIA LIMITED 6388.45 25.93 14.49 14712.60 5850.55 / 10526.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
ZENOTECH LABORATORIES LTD. 69.10 50.81 4.65 421.72 52.00 / 81.00
AMRUTAJAN HEALTH LTD 742.65 47.73 7.44 2147.05 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6566.50 109.81 23.05 16416.25 3715.05 / 7550.00
BLISS GVS PHARMA LTD 114.00 15.68 1.20 1194.01 77.65 / 148.95
ABBOTT INDIA LIMITED 28602.85 50.60 16.43 60781.06 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 66.80
  • 26 Days 62.80
  • 10 Days 64.70
  • 50 Days 62.60
  • 12 Days 64.20
  • 100 Days 64.50
  • 20 Days 63.10
  • 200 Days 57.60
70.39
PIVOT
First Resistance 73.11
Second Resistance 77.11
Third Resistance 79.83
First Support 66.39
Second Support 63.67
Third Support 59.67
RSI 73.82
MACD 1.36
Commodity Channel Index (CCI) 289.59
ADX 33.86
Williams % R -34.66

Over 1 Month

down

15.37

Over 3 Months

down

4.49

Over 6 Months

down

-9.17

Over 1 Year

down

23.65

Over 3 Years

down

11.94

Over 5 Years

down

33.32

ZENOTECH LABORATORIES LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ZENOTECH LABORATORIES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
31.15
Promoter Holdings
68.84
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sun Pharmaceutical Industries Limited Shareholding of Promoter and Promoter Group 4.2014578E7 68.84
Padmasree Chigurupati Public Shareholding 3209982.0 5.26
Pat Financial Consultants Private Limited Public Shareholding 2426000.0 3.98
Dr. Jayaram Chigurupati Public Shareholding 2192632.0 3.59
Minal Bharat Patel Public Shareholding 1213322.0 1.99
Zenotech Llc Public Shareholding 692791.0 1.14

ZENOTECH LABORATORIES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ZENOTECH LABORATORIES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ZENOTECH LABORATORIES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Zenotech Laboratories Ltd?

Answer Field

The share price of Zenotech Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 66.80.

What is the Market Cap of Zenotech Laboratories Ltd?

Answer Field

The market cap of Zenotech Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 407.70 Cr. as of now.

What is the 52 Week High and Low of Zenotech Laboratories Ltd?

Answer Field

The 52 Week High and Low of Zenotech Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 81.00 and ₹ 52.00.

How to Buy Zenotech Laboratories Ltd share?

Answer Field

You can trade in Zenotech Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Zenotech Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 23.65%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader